(PharmaNewsWire.Com, August 15, 2020 ) The protein stability analysis market size is expected to grow from USD 1.2 billion in 2018 to USD 2.1 billion by 2024, at a Compound Annual Growth Rate (CAGR) of 10.0 % during the forecast period. The growth of the protein stability analysis market is mainly driven by the growing adoption of open innovation models in pharmaceutical & biotechnology companies and increasing pharmaceutical outsourcing. Emerging economies will provide new growth opportunities for players in the protein stability analysis market.
Key players in the protein stability analysis market include Thermo Fisher Scientific, Inc. (US), Waters Corporation (US), Agilent Technologies, Inc. (US), PerkinElmer (US), Shimadzu Corporation (Japan), GE Healthcare (US), Malvern Panalytical Ltd (Spectris company) (US), Horiba, Ltd (Japan), Unchained Labs (US), NanoTemper Technologies (US), and Enzo Life Sciences, Inc. (US). These players have adopted various growth strategies from 2016 to 2019, such as product launches, collaborations, partnerships, acquisitions, and expansions to expand their presence in the protein stability analysis market.
Thermo Fisher Scientific is a global leader of the protein stability analysis market. The company geographically operates in over 50 countries, across North America, Europe, Asia, and Latin America. It focuses on expanding its presence in the protein stability analysis market by strategically investing in research and development activities. This strategy helps the company to launch new products in the market and strengthen its portfolio for this market. For instance, in 2018, Thermo Fisher Scientific launched Ultra-High Performance Liquid Chromatography Systems. The company’s strong product portfolio and continues efforts to develop innovative products is going to help the firm in maintaining its leading position in this market.
Waters Corporation is another prominent player of the protein stability analysis market. The company operates in 27 countries worldwide, with a strong geographical presence in Europe, the US, China, and Japan. The company focuses on new product launches as its key strategy. For instance, in 2016, the company launched Xevo TQ-XS mass spectrometry, a range of differential scanning calorimeters and chromatography columns. These product launches strengthen the company's product portfolio in the protein stability analysis products.
About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
